GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 87 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $87,734,000 | +33.6% | 3,670,817 | -18.4% | 0.00% | 0.0% |
Q4 2020 | $65,670,000 | +5.9% | 4,497,904 | +3.0% | 0.00% | 0.0% |
Q3 2020 | $62,027,000 | +13.3% | 4,368,133 | +17.3% | 0.00% | 0.0% |
Q2 2020 | $54,759,000 | +361.8% | 3,722,544 | +29.3% | 0.00% | +100.0% |
Q1 2020 | $11,859,000 | -22.1% | 2,878,551 | -9.0% | 0.00% | 0.0% |
Q4 2019 | $15,218,000 | -10.1% | 3,163,795 | +13.2% | 0.00% | 0.0% |
Q3 2019 | $16,935,000 | -3.6% | 2,794,472 | +3.3% | 0.00% | 0.0% |
Q2 2019 | $17,564,000 | -9.1% | 2,706,362 | -0.7% | 0.00% | 0.0% |
Q1 2019 | $19,321,000 | +44.6% | 2,725,055 | -0.9% | 0.00% | 0.0% |
Q4 2018 | $13,366,000 | -30.4% | 2,750,164 | +5.2% | 0.00% | 0.0% |
Q3 2018 | $19,207,000 | +16.8% | 2,613,213 | +1.4% | 0.00% | 0.0% |
Q2 2018 | $16,451,000 | +19.5% | 2,578,273 | +1.9% | 0.00% | 0.0% |
Q1 2018 | $13,762,000 | +35.3% | 2,529,816 | +3.7% | 0.00% | – |
Q4 2017 | $10,174,000 | -55.3% | 2,439,663 | +3.3% | 0.00% | -100.0% |
Q3 2017 | $22,747,000 | -11.4% | 2,362,101 | +8.9% | 0.00% | 0.0% |
Q2 2017 | $25,664,000 | +2.3% | 2,169,476 | +10.9% | 0.00% | 0.0% |
Q1 2017 | $25,084,000 | +8.0% | 1,956,681 | +3.1% | 0.00% | 0.0% |
Q4 2016 | $23,231,000 | +18.8% | 1,897,990 | +14.5% | 0.00% | 0.0% |
Q3 2016 | $19,562,000 | +37.0% | 1,657,870 | +1.0% | 0.00% | 0.0% |
Q2 2016 | $14,279,000 | +76.3% | 1,641,312 | +6.8% | 0.00% | 0.0% |
Q1 2016 | $8,097,000 | -29.8% | 1,536,448 | +3.4% | 0.00% | 0.0% |
Q4 2015 | $11,535,000 | -95.0% | 1,486,437 | -83.9% | 0.00% | -88.9% |
Q3 2015 | $229,981,000 | +1849.2% | 9,258,055 | +610.9% | 0.01% | +800.0% |
Q2 2015 | $11,799,000 | -28.4% | 1,302,316 | +2.6% | 0.00% | 0.0% |
Q1 2015 | $16,476,000 | +1.9% | 1,269,398 | +6.8% | 0.00% | 0.0% |
Q4 2014 | $16,169,000 | +58.1% | 1,188,058 | +4.2% | 0.00% | 0.0% |
Q3 2014 | $10,228,000 | -30.9% | 1,140,207 | +4.3% | 0.00% | 0.0% |
Q2 2014 | $14,797,000 | +42.0% | 1,093,631 | +4.3% | 0.00% | 0.0% |
Q1 2014 | $10,422,000 | -13.3% | 1,048,468 | +16.1% | 0.00% | 0.0% |
Q4 2013 | $12,017,000 | +12.4% | 902,858 | +2.6% | 0.00% | 0.0% |
Q3 2013 | $10,696,000 | +43.0% | 880,348 | +21.7% | 0.00% | 0.0% |
Q2 2013 | $7,478,000 | – | 723,156 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,500,000 | $25,725,000 | 3.13% |
CADIAN CAPITAL MANAGEMENT, LP | 3,830,399 | $28,153,000 | 1.28% |
Mesirow Financial Investment Management, Inc. | 33,001 | $243,000 | 1.25% |
Bellevue Group AG | 1,339,502 | $9,845,000 | 0.62% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 260,000 | $1,912,000 | 0.58% |
Lyon Street Capital, LLC | 109,850 | $807,000 | 0.50% |
Private Wealth Partners, LLC | 300,000 | $2,205,000 | 0.34% |
Penn Capital Management Company, LLC | 455,064 | $3,345,000 | 0.25% |
HighTower Advisors, LLC | 2,337,132 | $17,179,000 | 0.12% |
Schonfeld Strategic Advisors LLC | 376,000 | $2,763,000 | 0.12% |